J. Goldman & Co’s ResMed RMD Stock Holding History

J. Goldman & Co’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$2.24M	–	611
2025 Q1	$2.24M	Buy	+10,000	New	+$2.33M	0.06%	280
2024 Q2	–	Sell	-72,500	Closed	-$14.4M	–	563
2024 Q1	$14.4M	Buy	+72,500	New	+$13.3M	0.46%	69

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

J. Goldman & Co's RMD Position: Q2 2025 in Review

J. Goldman & Co sold out of ResMed (RMD) in Q2 2025, closing a stake of 19,599 shares — an estimated $4.39M sold.

J. Goldman & Co first reported a position in RMD in Q1 2025 and held it in 1 quarter. The position peaked at $4.39M in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

J. Goldman & Co reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
J. Goldman & Co sold 19,599 ResMed shares in Q2 2025, an estimated $4.39M.
J. Goldman & Co first reported a position in ResMed in Q1 2025 and held it in 1 quarter.
J. Goldman & Co's ResMed position peaked at $4.39M in Q1 2025.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.